Month: <span>April 2025</span>
Month: April 2025

Evidence for improved glucose metrics and perinatal outcomes with continuous glucose monitoring compared to self-monitoring in diabetes during pregnancy

Am J Obstet Gynecol. 2025 Apr 9:S0002-9378(25)00217-0. doi: 10.1016/j.ajog.2025.04.010. Online ahead of print. ABSTRACT OBJECTIVE: Continuous glucose monitoring (CGM) is recommended for pregnant women with …

Recurrence of Primary Sclerosing Cholangitis After Pediatric Liver Transplantation: A Single-Center, Retrospective Study in Japan

Pediatr Transplant. 2025 May;29(3):e70078. doi: 10.1111/petr.70078. ABSTRACT AIM: Liver transplantation (LT) is a well-accepted treatment for primary sclerosing cholangitis (PSC) with generally good outcomes, although …

Physical activity and sedentary behaviour amongst children with obesity – exploring cross-sectional associations between child and parent

J Act Sedentary Sleep Behav. 2025 Feb 13;4(1):2. doi: 10.1186/s44167-025-00072-0. ABSTRACT BACKGROUND: Physical activity (PA) in childhood is critical for establishing a healthy lifestyle across …

Nedl1 knockout ameliorates cognitive impairment and improves epilepsy threshold in pilocarpine-induced epileptic mice

Acta Epileptol. 2025 Jan 13;7(1):5. doi: 10.1186/s42494-024-00186-z. ABSTRACT BACKGROUND: Epilepsy is a common neurological disorder. The homologous to E6-AP carboxy terminus (HECT) E3 ligase is …

A systematic review and meta-analysis of the first decade of compositional data analyses of 24-hour movement behaviours, health, and well-being in school-aged children

J Act Sedentary Sleep Behav. 2025 Mar 27;4(1):4. doi: 10.1186/s44167-025-00076-w. ABSTRACT INTRODUCTION: Movement behaviours (e.g., sleep, sedentary behaviour, light physical activity [LPA], moderate to vigorous …

Exploring physiological beta-hydroxybutyrate level in children treated with the classical ketogenic diet for drug-resistant epilepsy

Acta Epileptol. 2025 Feb 7;7(1):10. doi: 10.1186/s42494-024-00199-8. ABSTRACT BACKGROUND: The ketogenic diet (KD) therapy is a primary treatment for drug-resistant epilepsy, and beta-hydroxybutyrate (BHB) is …